Treatment of Inherited Homocystinurias

Abstract

Inherited homocystinurias, have in common, accumulation of homocysteine with subsequent neurotoxicity; they also encompass two distinctive clinical entities: classical homocystinuria due to cystathionine β-synthase (CBS) deficiency and the rare inborn errors of cobalamin and folate metabolism. In the latter group, remethylation disorders of homocysteine to methionine (chiefly CblC defect and 5,10-methylenetetrahydrofolate reductase [MTHFR] deficiency) are by far the most frequently encountered situations. The natural history of CBS deficiency is relatively well known and described. Similarly, clinical presentations of remethylation defects are becoming better recognized and reported. Conversely, few data are available regarding treatment of these disorders, especially for remethylation defects. In this review, after an overview of the metabolic pathophysiology and the clinical features of inherited homocystinurias due to CBS deficiency, CblC defect, and MTHFR deficiency, we focus on present and prospective therapeutic approaches.

Keywords

homocystinurias - cystathionine β-synthase deficiency - remethylation disorders

• References

• 1 Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 2006; 29 (1) 3-20
• 2 Yap S, Naughten ER, Wilcken B, Wilcken DE, Boers GH. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost 2000; 26 (3) 335-340
• 3 Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997; 20 (2) 295-300
• 4 Quadros EV. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol 2010; 148 (2) 195-204
• 5 Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet 2011; 157 (1) 33-44
• 6 Watkins D, Rosenblatt DS. Update and new concepts in vitamin responsive disorders of folate transport and metabolism. J Inherit Metab Dis 2012; 35 (4) 665-670
• 7 Mudd SH, Cantoni GL. Activation of methionine for transmethylation. III. The methionine-activating enzyme of Bakers' yeast. J Biol Chem 1958; 231 (1) 481-492
• 8 Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, Kruger WD. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet 1996; 5 (12) 1851-1858
• 9 Sunden SL, Renduchintala MS, Park EI, Miklasz SD, Garrow TA. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys 1997; 345 (1) 171-174
• 10 Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007; 45 (12) 1694-1699
• 11 Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003; 26 (3) 137-146
• 12 Surtees R. Demyelination and inborn errors of the single carbon transfer pathway. Eur J Pediatr 1998; 157 (Suppl. 02) S118-S121
• 13 Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 2012; 35 (1) 91-102
• 14 Hannibal L, Kim J, Brasch NE , et al. Processing of alkylcobalamins in mammalian cells: a role for the MMACHC (cblC) gene product. Mol Genet Metab 2009; 97 (4) 260-266
• 15 Kim J, Gherasim C, Banerjee R. Decyanation of vitamin B12 by a trafficking chaperone. Proc Natl Acad Sci USA 2008; 105 (38) 14551-14554
• 16 Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes. J Inherit Metab Dis 2012; 35 (1) 103-114
• 17 Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis 2011; 34 (1) 127-135
• 18 Mudd SH, Skovby F, Levy HL , et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985; 37 (1) 1-31
• 19 Walter JH, Wraith JE, White FJ, Bridge C, Till J. Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr 1998; 157 (Suppl. 02) S71-S76
• 20 Ogier de Baulny H, Gérard M, Saudubray JM, Zittoun J. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 1998; 157 (Suppl. 02) S77-S83
• 21 Weisfeld-Adams JD, Morrissey MA, Kirmse BM , et al. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. Mol Genet Metab 2010; 99 (2) 116-123
• 22 Tortorelli S, Turgeon CT, Lim JS , et al. Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry. J Pediatr 2010; 157 (2) 271-275
• 23 Baethmann M, Wendel U, Hoffmann GF , et al. Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics 2000; 31 (6) 314-317
• 24 Schiff M, Benoist JF, Tilea B, Royer N, Giraudier S, Ogier de Baulny H. Isolated remethylation disorders: do our treatments benefit patients?. J Inherit Metab Dis 2011; 34 (1) 137-145
• 25 Thauvin-Robinet C, Roze E, Couvreur G , et al. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J Neurol Neurosurg Psychiatry 2008; 79 (6) 725-728
• 26 Schiff M, Benoist JF, Aïssaoui S , et al. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?. PLoS ONE 2011; 6 (7) e21932
• 27 Farquharson J, Adams JF. The forms of vitamin B12 in foods. Br J Nutr 1976; 36 (1) 127-136
• 28 Rosenblatt DS, Fenton WA. Inherited disorders of folate and cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Valle D, Sly WS, , eds. Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001: 3897-3933
• 29 Carmel R, Watkins D, Goodman SI, Rosenblatt DS. Hereditary defect of cobalamin metabolism (cblG mutation) presenting as a neurologic disorder in adulthood. N Engl J Med 1988; 318 (26) 1738-1741
• 30 Schuh S, Rosenblatt DS, Cooper BA , et al. Homocystinuria and megaloblastic anemia responsive to vitamin B12 therapy. An inborn error of metabolism due to a defect in cobalamin metabolism. N Engl J Med 1984; 310 (11) 686-690
• 31 Harding CO, Arnold G, Barness LA, Wolff JA, Rosenblatt DS. Functional methionine synthase deficiency due to cblG disorder: a report of two patients and a review. Am J Med Genet 1997; 71 (4) 384-390
• 32 Mellman I, Willard HF, Youngdahl-Turner P, Rosenberg LE. Cobalamin coenzyme synthesis in normal and mutant human fibroblasts. Evidence for a processing enzyme activity deficient in cblC cells. J Biol Chem 1979; 254 (23) 11847-11853
• 33 Carrillo-Carrasco N, Sloan J, Valle D, Hamosh A, Venditti CP. Hydroxocobalamin dose escalation improves metabolic control in cblC. J Inherit Metab Dis 2009; 32 (6) 728-731
• 34 Andersson HC, Shapira E. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). J Pediatr 1998; 132 (1) 121-124
• 35 Pentieva K, McNulty H, Reichert R , et al. The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men. J Nutr 2004; 134 (3) 580-585
• 36 Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008; (4) CD004514
• 37 Gregory III JF. Chemical and nutritional aspects of folate research: analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates. Adv Food Nutr Res 1989; 33: 1-101
• 38 Hyland K, Shoffner J, Heales SJ. Cerebral folate deficiency. J Inherit Metab Dis 2010; 33 (5) 563-570
• 39 Wilcken B, Turner B. Homocystinuria. Reduced folate levels during pyridoxine treatment. Arch Dis Child 1973; 48 (1) 58-62
• 40 Smulders YM, Smith DE, Kok RM , et al. Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap. Br J Haematol 2006; 132 (5) 623-629
• 41 Verlinde PH, Oey I, Hendrickx ME, Van Loey AM, Temme EH. L-ascorbic acid improves the serum folate response to an oral dose of [6S]-5-methyltetrahydrofolic acid in healthy men. Eur J Clin Nutr 2008; 62 (10) 1224-1230
• 42 Li D, Karp N, Wu Q , et al. Mefolinate (5-methyltetrahydrofolate), but not folic acid, decreases mortality in an animal model of severe methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 2008; 31 (3) 403-411
• 43 Fowler B. Genetic defects of folate and cobalamin metabolism. Eur J Pediatr 1998; 157 (Suppl. 02) S60-S66
• 44 Sibani S, Leclerc D, Weisberg IS , et al. Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutation. Hum Mutat 2003; 21 (5) 509-520
• 45 Bendich A, Cohen M. Vitamin B6 safety issues. Ann N Y Acad Sci 1990; 585: 321-330
• 46 Hartmann H, Fingerhut M, Jakobs C, Plecko B. Status epilepticus in a neonate treated with pyridoxine because of a familial recurrence risk for antiquitin deficiency: pyridoxine toxicity?. Dev Med Child Neurol 2011; 53 (12) 1150-1153
• 47 Delgado-Reyes CV, Wallig MA, Garrow TA. Immunohistochemical detection of betaine-homocysteine S-methyltransferase in human, pig, and rat liver and kidney. Arch Biochem Biophys 2001; 393 (1) 184-186
• 48 Smolin LA, Benevenga NJ, Berlow S. The use of betaine for the treatment of homocystinuria. J Pediatr 1981; 99 (3) 467-472
• 49 Bartholomew DW, Batshaw ML, Allen RH , et al. Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr 1988; 112 (1) 32-39
• 50 Allen RH, Stabler SP, Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 1993; 42 (11) 1448-1460
• 51 Matthews A, Johnson TN, Rostami-Hodjegan A , et al. An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. Br J Clin Pharmacol 2002; 54 (2) 140-146
• 52 Yaghmai R, Kashani AH, Geraghty MT , et al. Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am J Med Genet 2002; 108 (1) 57-63
• 53 Yap S, Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis 1998; 21 (7) 738-747
• 54 Strauss KA, Morton DH, Puffenberger EG , et al. Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab 2007; 91 (2) 165-175
• 55 Schwahn BC, Laryea MD, Chen Z , et al. Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency. Biochem J 2004; 382 (Pt 3) 831-840
• 56 Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 1991; 338 (8782–8783) 1550-1554
• 57 Abeling NG, van Gennip AH, Blom H , et al. Rapid diagnosis and methionine administration: basis for a favourable outcome in a patient with methylene tetrahydrofolate reductase deficiency. J Inherit Metab Dis 1999; 22 (3) 240-242
• 58 Al-Essa MA, Al Amir A, Rashed M , et al. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography of the brain, MR spectroscopy, and therapeutic attempts in methylenetetrahydrofolate reductase deficiency. Brain Dev 1999; 21 (5) 345-349
• 59 Harpey JP, Rosenblatt DS, Cooper BA, Le Moël G, Roy C, Lafourcade J. Homocystinuria caused by 5,10-methylenetetrahydrofolate reductase deficiency: a case in an infant responding to methionine, folinic acid, pyridoxine, and vitamin B12 therapy. J Pediatr 1981; 98 (2) 275-278
• 60 Wendel U, Bremer HJ. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 1984; 142 (2) 147-150
• 61 Clayton PT, Smith I, Harding B, Hyland K, Leonard JV, Leeming RJ. Subacute combined degeneration of the cord, dementia and parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatry 1986; 49 (8) 920-927
• 62 Holme E, Kjellman B, Ronge E. Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 1989; 64 (7) 1061-1064
• 63 Finkelstein JD. Inborn errors of sulfur-containing amino acid metabolism. J Nutr 2006; 136 (6, Suppl) 1750S-1754S
• 64 Stead LM, Brosnan JT, Brosnan ME, Vance DE, Jacobs RL. Is it time to reevaluate methyl balance in humans?. Am J Clin Nutr 2006; 83 (1) 5-10
• 65 Huemer M, Simma B, Fowler B, Suormala T, Bodamer OA, Sass JO. Prenatal and postnatal treatment in cobalamin C defect. J Pediatr 2005; 147 (4) 469-472
• 66 Rosenblatt DS, Cooper BA, Schmutz SM, Zaleski WA, Casey RE. Prenatal vitamin B12 therapy of a fetus with methylcobalamin deficiency (cobalamin E disease). Lancet 1985; 1 (8438) 1127-1129
• 67 Garlick PJ. Toxicity of methionine in humans. J Nutr 2006; 136 (6, Suppl) 1722S-1725S
• 68 Coelho D, Kim JC, Miousse IR , et al. Mutations in ABCD4 cause a new inborn error of vitamin B(12) metabolism. Nat Genet 2012; 44 (10) 1152-1155